Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppina Abignano

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Rheumatology (Oxford, England)|September 22, 2018
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosisGiuseppina Abignano, Jelena Blagojevic, Lesley-Anne Bissell, et al.
Rheumatology (Oxford, England)|February 13, 2021
The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohortMaria-Grazia Lazzaroni, Emiliano Marasco, Corrado Campochiaro, et al.
Annals of the Rheumatic Diseases|August 9, 2019
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort studyGabriele Valentini, Dörte Huscher, Antonella Riccardi, et al.
Rheumatology (Oxford, England)|May 13, 2017
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR groupVeronika K Jaeger, Oliver Distler, Britta Maurer, et al.
The Lancet. Rheumatology|February 1, 2021
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey studyClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
Clinical and Experimental Rheumatology|April 18, 2020
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrumClodoveo Ferri, Dilia Giuggioli, Serena Guiducci, et al.
Clinical Rheumatology|May 15, 2025
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for RheumatologyMartina Orlandi, Giacomo De Luca, Clodoveo Ferri, et al.
Therapeutic Advances in Musculoskeletal Disease|July 16, 2025
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR)Martina Orlandi, Dilia Giuggioli, Clodoveo Ferri, et al.
Journal of Scleroderma and Related Disorders|February 9, 2024
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) RegistryValeria Riccieri, Greta Pellegrino, Edoardo Cipolletta, et al.
Journal of Autoimmunity|November 15, 2025
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for RheumatologyAntonio Tonutti, Francesca Motta, Gianluigi Bajocchi, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|September 22, 2018
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosisGiuseppina Abignano, Jelena Blagojevic, Lesley-Anne Bissell, et al.
Rheumatology (Oxford, England)|February 13, 2021
The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohortMaria-Grazia Lazzaroni, Emiliano Marasco, Corrado Campochiaro, et al.
Annals of the Rheumatic Diseases|August 9, 2019
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort studyGabriele Valentini, Dörte Huscher, Antonella Riccardi, et al.
Rheumatology (Oxford, England)|May 13, 2017
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR groupVeronika K Jaeger, Oliver Distler, Britta Maurer, et al.
The Lancet. Rheumatology|February 1, 2021
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey studyClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
Clinical and Experimental Rheumatology|April 18, 2020
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrumClodoveo Ferri, Dilia Giuggioli, Serena Guiducci, et al.
Clinical Rheumatology|May 15, 2025
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for RheumatologyMartina Orlandi, Giacomo De Luca, Clodoveo Ferri, et al.
Therapeutic Advances in Musculoskeletal Disease|July 16, 2025
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR)Martina Orlandi, Dilia Giuggioli, Clodoveo Ferri, et al.
Journal of Scleroderma and Related Disorders|February 9, 2024
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) RegistryValeria Riccieri, Greta Pellegrino, Edoardo Cipolletta, et al.
Journal of Autoimmunity|November 15, 2025
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for RheumatologyAntonio Tonutti, Francesca Motta, Gianluigi Bajocchi, et al.
Pageof 7